Skip to main content
Top

Current Colorectal Cancer Reports

Issue 1/2016

Content (7 Articles)

Colorectal Cancer Hepatic Metastases (MA Choti, Section Editor)

The Role of Neoadjuvant Chemotherapy in Patients With Resectable Colorectal Metastases: Where Are We Now?

Hans F. Schoellhammer, Gagandeep Singh, Yuman Fong

Personalized Medicine in Colorectal Cancer (D Cunningham and EC Smyth, Section Editors)

Optimizing Colorectal Cancer Care in Older Patients

Stavros Gkolfinopoulos, Panteleimon Kountourakis, Demetris Papamichael

Personalized Medicine in Colorectal Cancer (D Cunningham and EC Smyth, Section Editors)

Are Gene Signatures Ready for Use in the Selection of Patients for Adjuvant Treatment?

Cristina Santos Vivas, Rebeca Sanz-Pamplona, Julieta Grasselli, Nuria Mulet-Margalef, Ramon Salazar Soler

Open Access Personalized Medicine in Colorectal Cancer (D Cunningham and EC Smyth, Section Editors)

Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?

Christopher Coyle, Fay Helen Cafferty, Ruth Elizabeth Langley

Prevention and Early Detection (R Benamouzig, Section Editor)

Is Curcumin a Chemopreventive Agent for Colorectal Cancer?

Bernard Uzzan, Robert Benamouzig

Prevention and Early Detection (R Benamouzig, Section Editor)

How Can We Improve Adenoma Detection Rate?

Ashley Bond, Sanchoy Sarkar

Translational Colorectal Oncology (Y Jiang, Section Editor)

The Outlook for Immune Checkpoint Targeting Strategies in Colorectal Cancer

Michael A. Morse

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine